flupentixolmelitracen trade name frenxit franxit placida deanxit anxidreg danxipress mocalm combination two psychoactive agents flupentixol melitracen designed short term usage produced flupentixol thiazolyl thioanthracene antipsychotic melitracen tricyclic antidepressant low dose flupentixol antidepressant antianxiety effects melitracen antidepressant effect mixture two components used treat mild moderate mental disorders flupentixol acts dopamine receptor antagonist melitracen acts similar way tricyclic antidepressants blocking reuptake serotonin norepinephrine presynaptic terminals oral adult per tablet contains flupentixol mg melitracen mg tablet morning midday may double morning dose severe cases exceed tablets daily elderly per tablet contains flupentixol mg melitracen mg tablet morning severe cases tablet morning midday circulatory collapse depressed level consciousness due cause coma severe depression requiring hospitalisation electroconvulsive therapy recommended use states excitement overactivity unsafe porphyria caution used patients epilepsy parkinsons disease narrow angle glaucoma prostatic hypertrophy hypothyroidism hyperthyroidism liver disease cardiac disease arrhythmias severe respiratory disease renal failure myasthenia gravis phaeochromocytoma patients hypersensitivity thioxanthenes antipsychotics close monitoring changes behaviour suicidal thoughts clinical worsening initial part treatment recommended may impair control diabetes monitor blood glucose diabetics drowsiness dry mouth constipation vomiting dyspepsia diarrhoea abdominal pain nausea flatulence extrapyramidal effects especially initial phase treatment tachycardia palpitations prolonged qt interval hypotension thrombocytopenia neutropenia leukopenia agranulocytosis dyspnoea myalgia muscle rigidity micturition disorder urinary retention increased appetite weight abnormal glucose tolerance lfts insomnia depression nervousness agitation decreased libido increased risk adverse effects used alcohol may potentiate effects general anaesthetics anticoagulants prolong action neuromuscular blockers may increase anticholinergic effects atropine drugs anticholinergic activity may increase risk neurotoxicity used sibutramine lithium avoid concurrent usage drugs cause qt prolongation cardiac arrhythmias may inhibit metabolism tcas may antagonise effects adrenaline sympathomimetics reverse antihypertensive effects guanethidine flupentixol inhibits dopaminemediated effects blocking postsynaptic dopamine receptors cns melitracen tca anxiolytic properties low doses activating properties also bipolar thymoleptic absorption flupentixol readily absorbed gi tract distribution flupentixol bound plasma proteins widely distributed body crosses blood brain barrier metabolism flupentixol extensively hepatic metabolism excretion flupentixol excreted urine faeces form many metabolites melitracen belongs class nonselective monoamine reuptake inhibitors used management depression flupentixol belongs class thioxanthene derivatives antipsychotics brand names include drug article relating nervous system stub help wikipedia expanding ithttpsenwikipediaorgwikiflupentixolmelitracen